Manifold MarketsSin KYCDatos de resolución verificadosCalibración aceptableAviso de calidad de datosDatos de la fuente degradados
Datos del 26 oct 2026, 5:51 UTC · política pm-quality-4
Pronóstico comunitario actualNo 90.8%
Pronosticadores
16
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 3 horas
Desactualizado21 feb 23, 20:26 UTC31 dic 27, 22:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiReglas
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of malaria in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
